avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox15
|
ENSMUSG00000041287.5 | SRY (sex determining region Y)-box 15 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sox15 | mm10_v2_chr11_+_69655314_69655314 | 0.62 | 5.4e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
1.0 | 3.1 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.7 | 2.1 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.5 | 1.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.4 | 1.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 1.4 | GO:0061153 | negative regulation of interleukin-13 production(GO:0032696) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 0.3 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.3 | 0.3 | GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
0.3 | 2.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 0.8 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.2 | 0.7 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.2 | 0.8 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.2 | 1.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.2 | 3.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 2.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 1.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 2.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 1.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.5 | GO:2000325 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 2.6 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 2.2 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.3 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 1.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.0 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 2.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 1.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0021658 | rhombomere 3 morphogenesis(GO:0021658) |
0.0 | 3.9 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 0.5 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 1.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 2.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 2.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 3.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 3.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 11.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 4.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 2.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.8 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 3.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.8 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 1.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.5 | 2.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 3.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 3.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 4.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 4.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 2.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 2.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 4.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 1.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 3.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 2.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 2.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |